Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients

International Journal of Oncology

Volumn 40, Issue 5, 2012, Pages 1590-1600

  Yang, Shu ^a   Chen, Jiaxin ^b   Guo, Yi ^a   Lin, Hui ^b   Zhang, Zheng ^b   Feng, Guosheng ^b   Hao, Yanrong ^b   Cheng, Jinjian ^b   Liang, Ping ^b   Chen, Kehe ^b   Wu, Hai ^a   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b People's Hospital of the Guangxi Zhuang Autonomous Region   (China)

Author keywords

Differentially expressed gene; DNA microarray; Nasopharyngeal carcinoma; Pathway enrichment; Radiation resistant; Radiotherapy

Indexed keywords

CALCIUM ION; CYTOKINE; MOLECULAR MARKER; RECEPTOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; BIOSTATISTICS; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA REPAIR; FEMALE; GENE EXPRESSION; GENETIC RESISTANCE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; INFLAMMATION; INTRACELLULAR SIGNALING; MALE; MEMBRANE; NASOPHARYNX CARCINOMA; ONCOGENE; PREDICTION; PRIORITY JOURNAL; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR BIOPSY; TUMOR CELL;

ADULT; AGED; BIOPSY; CHINA; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; ZINC FINGERS;

EID: 84860307933     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1341     Document Type: Article

References (51)

1. Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005. (Pubitemid 40812341)
2. Hildesheim A and Levine PH: Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 15: 466-485, 1993. (Pubitemid 24072639)
3. Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9: 1-24, 2007. (Pubitemid 47398642)
4. Zheng X, Yan L, Nilsson B, Eklund G and Drettner B: Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 33: 867-872, 1994.
5. zur Hausen H, Schulte-Holthausen H, Klein G, et al: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056-1058, 1970.
6. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429, 2002. (Pubitemid 35370755)
7. Nielsen NH, Mikkelsen F and Hansen JP: Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population. Acta Pathol Microbiol Scand A 85: 850-858, 1977. (Pubitemid 8245849)
8. Dickson RI and Flores AD: Nasopharyngeal carcinoma: an evaluation of 134 patients treated between 1971-1980. Laryngoscope 95: 276-283, 1985. (Pubitemid 15137346)
9. Yeh SA, Tang Y, Lui CC, Huang YJ and Huang EY: Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62: 672-679, 2005. (Pubitemid 40779753)
10. DeNittis AS, Liu L, Rosenthal DI and Machtay M: Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy. Am J Clin Oncol 25: 93-95, 2002. (Pubitemid 34131038)
11. Lee AW, Poon YF, Foo W, et al: Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23: 261-270, 1992.
12. Leung SF, Teo PM, Shiu WW, Tsao SY and Leung TW: Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 20: 27-29, 1991.
13. Li T, Chen JX, Fu XP, et al: microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep 25: 1353-1363, 2011.
14. Xiong S, Wang Q, Zheng L, Gao F and Li J: Identification of candidate molecular markers of nasopharyngeal Carcinoma by tissue microarray and in situ hybridization. Med Oncol: November 2010 (E-pub ahead of print).
15. Wong YF, Sahota DS, Cheung TH, et al: Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 12: 189-193, 2006. (Pubitemid 43894334)
16. Ogawa K, Utsunomiya T, Mimori K, et al: Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 28: 705-713, 2006.
17. Higo M, Uzawa K, Kouzu Y, et al: Identification of candidate radioresistant genes in human squamous cell carcinoma cells through gene expression analysis using DNA microarrays. Oncol Rep 14: 1293-1298, 2005.
18. Guo WF, Lin RX, Huang J, et al: Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res 164: 27-35, 2005. (Pubitemid 40885227)
19. Fukuda K, Sakakura C, Miyagawa K, et al: Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91: 1543-1550, 2004. (Pubitemid 39486360)
20. Chang JT, Chan SH, Lin CY, et al: Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 6: 2271-2279, 2007. (Pubitemid 47294755)
21. Guo Y, Zhu XD, Qu S, et al: Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol 40: 85-92, 2011.
22. Feng XP, Yi H, Li MY, et al: Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 70: 3450-3462, 2010.
23. Qu Y, Zhang H, Zhao S, Hong J and Tang C: The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma. Oncol Rep 23: 1005-1011, 2010.
24. He YX, Zhong PP, Yan SS, et al: DNA-dependent protein kinase activity and radiosensitivity of nasopharyngeal carcinoma cell lines CNE1/CNE2. Sheng Li Xue Bao 59: 524-533, 2007.
25. Schwarz SB, Schaffer PM, Kulka U, Ertl-Wagner B, Hell R and Schaffer M: The effect of radio-adaptive doses on HT29 and GM637 cells. Radiat Oncol 3: 12, 2008.
26. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
27. Eisen MB, Spellman PT, Brown PO and Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998. (Pubitemid 29003722)
28. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC and Conklin BR: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31: 19-20, 2002.
29. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC and Conklin BR: MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4: R7, 2003.
30. -/- macrophages: regulation of proliferation, differentiation, and morphology. J Leukoc Biol 84: 852-863, 2008.
31. Pixley FJ and Stanley ER: CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638, 2004. (Pubitemid 39440612)
32. Kacinski BM: CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27: 79-85, 1995.
33. Smith HO, Anderson PS, Kuo DY, et al: The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1: 313-325, 1995.
34. Lin EY, Nguyen AV, Russell RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727-740, 2001.
35. Wyckoff J, Wang W, Lin EY, et al: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029, 2004. (Pubitemid 39331012)
36. Goswami S, Sahai E, Wyckoff JB, et al: Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65: 5278-5283, 2005. (Pubitemid 40827339)
37. Condeelis J and Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266, 2006. (Pubitemid 43121975)
38. Sampaio NG, Yu W, Cox D, et al: Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion. J Cell Sci 124: 2021-2031, 2011.
39. 2+/calmodulin-dependent kinase II contribute to G2/M cell cycle arrest and survival of irradiated leukemia cells. Cellular physiology and biochemistry. Int J Exp Cell Physiol Biochem Pharmacol 26: 597-608, 2010.
40. Steinhardt RA and Alderton J: Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 332: 364-366, 1988.
41. Taylor JT, Zeng XB, Pottle JE, et al: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 14: 4984-4991, 2008.
42. 2+ for cancer cell proliferation and survival. Nat Rev Cancer 8: 361-375, 2008.
43. Coste B, Mathur J, Schmidt M, et al: Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 330: 55-60, 2010.
44. Lenzo JC, Turner AL, Cook AD, et al: Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. Immunol Cell Biol: July 5, 2011 (E-pub ahead of print) doi: 10.1038/icb.2011.58.
45. Fantl WJ, Johnson DE and Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993. (Pubitemid 23237878)
46. Lu M and Krauss RS: N-cadherin ligation, but not Sonic hedgehog binding, initiates Cdo-dependent p38alpha/beta MAPK signaling in skeletal myoblasts. Proc Natl Acad Sci USA 107: 4212-4217, 2010.
47. Kang YJ, Chen J, Otsuka M, et al: Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J Immunol 180: 5075-5082, 2008.
48. Wagner EF and Nebreda AR: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549, 2009.
49. Thornton TM and Rincon M: Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 5: 44-51, 2009.
50. Karahashi H, Nagata K, Ishii K and Amano F: A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide- treated macrophage-like cell line, J774.1. Biochim Biophys Acta 1502: 207-223, 2000.
51. Elenitoba-Johnson KS, Jenson SD, Abbott RT, et al: Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci USA 100: 7259-7264, 2003. (Pubitemid 36706426)